San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, AscentX Medical is raising $5,186,319.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Stefan Lemperle played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AscentX Medical

AscentX Medical is a privately held Medical Technology Company focused on the clinical development and marketing of novel, minimal-invasive endoscopic injection procedures designed to address unmet medical needs amongst both patients and physicians and help cure various debilitating and socially isolating medical conditions of the growing aging population. The Company believes that its proprietary technology platform, once approved for clinical use, has the potential to create new standards of care via its respective procedures, as they are designed to provide safer, more user-friendly, least-invasive, curative, and more cost-effective outpatient treatments.

To learn more about AscentX Medical, visit http://ascentxmedical.com/

Contact:
Stefan Lemperle, Chief Executive Officer
833-272-3689
stefan@ascentxmedical.com
https://www.linkedin.com/in/stefan-lemperle-md-ph-d-mba-4497803/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved